Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07217652 · ClinicalTrials.gov registry record · NA

Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive Flexibility

A NA study of Schizophrenia and Attention Deficit Disorder With Hyperactivity (ADHD), sponsored by Kai Hwang.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07217652: Recruiting NA study of Schizophrenia and Attention Deficit Disorder With Hyperactivity (ADHD), sponsored by Kai Hwang.

NCT07217652 is a NA study of Schizophrenia and Attention Deficit Disorder With Hyperactivity (ADHD) that is actively recruiting participants, run by Kai Hwang. The registered enrollment target is 100 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07217652, a NA study of Schizophrenia and Attention Deficit Disorder With Hyperactivity (ADHD), is actively recruiting participants, sponsored by Kai Hwang.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this basic experimental research study is to examine how the human thalamus supports flexible thinking and behavior. Specifically, the research aims to elucidate how the mediodorsal (MD) thalamus encodes and updates "context"-the mental framework that determines which rules or actions are relevant in a given situation. This work may contribute to understanding why certain psychiatric conditions, such as schizophrenia and ADHD, involve difficulties with cognitive flexibility and control. The primary research questions are: Does the MD thalamus represent the context that organizes how working memory guides task selection? Does the MD thalamus signal when context needs to be updated after a change in task demands? Do these thalamic representations support generalization to new situations or rules? Participants will complete cognitive tasks while undergoing high-resolution brain imaging using 7-Tesla MRI. The investigators will combine behavioral data, computational modeling, and advanced neuroimaging analyses to examine how the thalamus interacts with the cortex during flexible decision-making.

Primary Outcome

This outcome measure will quantify the extent to which multivariate patterns of brain activity in the MD thalamus encode task context. High-resolution 7-Tesla fMRI data will be analyzed using computational modeling and multivariate pattern analysis (MVPA) techniques. The primary metric will be decoding accuracy, expressed as a percentage ranging from 0% to 100%. Decoding accuracy reflects how well task contexts for working memory, cognitive control, and decision-making can be predicted from MD

Interventions

  • OTHER High-resolution fMRI during working memory, cognitive control, and decision-making tasks

Study Locations (1)

Iowa

  • The University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-12-01
Est. Completion 2030-07-30
Phase NA
Kai Hwang

2 total trials

What NCT07217652 shows while recruiting

NCT07217652 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (54% lower).

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which High-resolution fMRI during working memory, cognitive control, and decision-making tasks is the first listed.

NCT07217652 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT07217652 about?

NCT07217652 is a clinical study titled "Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive Flexibility". The goal of this basic experimental research study is to examine how the human thalamus supports flexible thinking and behavior. Specifically, the research aims to elucidate how the mediodorsal (MD) thalamus encodes and updates "context"-the mental framework that determines which rules or actions ar...

What is the current status of trial NCT07217652?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-12-01. Estimated completion is 2030-07-30.

What conditions does trial NCT07217652 study?

This clinical trial studies the following conditions: Schizophrenia, Attention Deficit Disorder With Hyperactivity (ADHD).

What interventions are being tested in trial NCT07217652?

The interventions under investigation include: High-resolution fMRI during working memory, cognitive control, and decision-making tasks (OTHER).

Who is sponsoring clinical trial NCT07217652?

This trial is sponsored by Kai Hwang, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07217652 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07217652's enrollment target sits among peer trials

100 140th of 315 higher than 169 of 315 other Schizophrenia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01773278 · 100 participants · Phase 2

    Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07217652, the US trial registry maintained by the National Library of Medicine. NCT07217652 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.